We report 2 cases of sensitized patients who were successfully treated with bortezomib therapy resulting in reduction of donor-specific antibodies (DSA). Our cases illustrate the synergistic effects of combination therapy that includes bortezomib on prevention and treatment of AMR in highly sensitized patients. Moving forward, long-term data on sensitized patients treated with bortezomib are needed to fully evaluate the impact of this therapy.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
sensitized patients
16
bortezomib prevention
8
prevention treatment
8
patients treated
8
treated bortezomib
8
bortezomib
4
treatment rejection
4
sensitized
4
rejection sensitized
4
patients
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!